FDA Brief

Warning letters Drugs

FDA warning letter to

ISOThrive, Inc.

Issued Feb 4, 2025Posted Feb 11, 2025Center for Drug Evaluation and Research (CDER)

Clinical Investigator. We haven't summarized this letter yet. Read it on fda.gov.